HEADER PROTEIN BINDING/INHIBITOR 22-JUN-18 6DUV TITLE CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN OF HUMAN BRD4 IN COMPLEX TITLE 2 WITH MS417 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BRD4 SECOND BROMODOMAIN; COMPND 5 SYNONYM: PROTEIN HUNK1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) CODON PLUS RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A-LIC KEYWDS PROTEIN-SMALL MOLECULE INHIBITOR COMPLEX, PROTEIN BINDING, PROTEIN KEYWDS 2 BINDING-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.BABAULT,M.M.ZHOU REVDAT 3 13-MAR-24 6DUV 1 REMARK REVDAT 2 01-JAN-20 6DUV 1 REMARK REVDAT 1 26-JUN-19 6DUV 0 JRNL AUTH N.BABAULT,Q.ZHANG,G.ZHANG,M.M.ZHOU,L.ZENG JRNL TITL ROLE OF BOUND WATER MOLECULES IN DIFFERENTIAL RECOGNITION OF JRNL TITL 2 DI-ACETYLATED HISTONE PEPTIDES BY THE BRD4 BROMODOMAINS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 33109 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1682 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.2078 - 4.1200 1.00 2863 143 0.1527 0.1795 REMARK 3 2 4.1200 - 3.2706 1.00 2723 143 0.1432 0.1729 REMARK 3 3 3.2706 - 2.8572 1.00 2685 143 0.1664 0.1826 REMARK 3 4 2.8572 - 2.5960 1.00 2696 149 0.1633 0.1919 REMARK 3 5 2.5960 - 2.4100 1.00 2640 157 0.1601 0.2025 REMARK 3 6 2.4100 - 2.2679 1.00 2649 146 0.1598 0.2142 REMARK 3 7 2.2679 - 2.1543 1.00 2676 141 0.1577 0.1789 REMARK 3 8 2.1543 - 2.0606 1.00 2649 141 0.1571 0.1614 REMARK 3 9 2.0606 - 1.9812 1.00 2643 136 0.1612 0.2033 REMARK 3 10 1.9812 - 1.9129 0.98 2576 134 0.1889 0.2135 REMARK 3 11 1.9129 - 1.8531 0.91 2405 135 0.2082 0.2393 REMARK 3 12 1.8531 - 1.8001 0.84 2222 114 0.2355 0.2247 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.160 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.880 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1987 REMARK 3 ANGLE : 1.625 2677 REMARK 3 CHIRALITY : 0.048 260 REMARK 3 PLANARITY : 0.007 341 REMARK 3 DIHEDRAL : 7.211 1645 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 349 THROUGH 399 ) REMARK 3 ORIGIN FOR THE GROUP (A): -40.3054 14.5967 7.4084 REMARK 3 T TENSOR REMARK 3 T11: 0.1439 T22: 0.1441 REMARK 3 T33: 0.1412 T12: -0.0230 REMARK 3 T13: 0.0009 T23: -0.0151 REMARK 3 L TENSOR REMARK 3 L11: 0.6124 L22: 0.9332 REMARK 3 L33: 0.9416 L12: -0.2198 REMARK 3 L13: 0.1407 L23: -0.5252 REMARK 3 S TENSOR REMARK 3 S11: -0.0518 S12: 0.1640 S13: 0.0032 REMARK 3 S21: -0.1199 S22: 0.0939 S23: 0.1136 REMARK 3 S31: -0.0683 S32: 0.0382 S33: -0.0001 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 400 THROUGH 458 ) REMARK 3 ORIGIN FOR THE GROUP (A): -36.5300 9.7868 6.6361 REMARK 3 T TENSOR REMARK 3 T11: 0.1853 T22: 0.1407 REMARK 3 T33: 0.1564 T12: 0.0157 REMARK 3 T13: -0.0216 T23: 0.0003 REMARK 3 L TENSOR REMARK 3 L11: 0.2231 L22: 1.1662 REMARK 3 L33: 0.4981 L12: -0.1623 REMARK 3 L13: -0.1049 L23: -0.2834 REMARK 3 S TENSOR REMARK 3 S11: 0.0529 S12: 0.0567 S13: 0.0078 REMARK 3 S21: -0.0539 S22: 0.0178 S23: 0.0388 REMARK 3 S31: 0.2630 S32: 0.0448 S33: 0.0001 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 350 THROUGH 389 ) REMARK 3 ORIGIN FOR THE GROUP (A): -23.2495 -8.0696 11.6425 REMARK 3 T TENSOR REMARK 3 T11: 0.2198 T22: 0.1723 REMARK 3 T33: 0.2528 T12: 0.0517 REMARK 3 T13: 0.0001 T23: 0.0088 REMARK 3 L TENSOR REMARK 3 L11: 0.6867 L22: 0.6693 REMARK 3 L33: 0.6138 L12: -0.0859 REMARK 3 L13: 0.0575 L23: -0.6277 REMARK 3 S TENSOR REMARK 3 S11: -0.0229 S12: -0.1204 S13: 0.0269 REMARK 3 S21: -0.1829 S22: -0.0800 S23: -0.3746 REMARK 3 S31: 0.1638 S32: 0.1577 S33: -0.0629 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 390 THROUGH 458 ) REMARK 3 ORIGIN FOR THE GROUP (A): -26.1475 -2.9800 6.9988 REMARK 3 T TENSOR REMARK 3 T11: 0.2480 T22: 0.1250 REMARK 3 T33: 0.1685 T12: 0.0402 REMARK 3 T13: 0.0290 T23: -0.0026 REMARK 3 L TENSOR REMARK 3 L11: 1.2201 L22: 1.7003 REMARK 3 L33: 0.4965 L12: -0.2047 REMARK 3 L13: -0.0340 L23: -0.6509 REMARK 3 S TENSOR REMARK 3 S11: -0.0595 S12: -0.0353 S13: 0.1191 REMARK 3 S21: -0.4891 S22: -0.0237 S23: -0.1918 REMARK 3 S31: 0.0082 S32: 0.0372 S33: -0.0247 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 350 THROUGH 355 OR REMARK 3 RESID 357 THROUGH 387 OR RESID 389 REMARK 3 THROUGH 426 OR RESID 428 THROUGH 435 OR REMARK 3 RESID 437 THROUGH 443 OR RESID 445 REMARK 3 THROUGH 458)) REMARK 3 SELECTION : (CHAIN B AND (RESID 350 THROUGH 355 OR REMARK 3 RESID 357 THROUGH 387 OR RESID 389 REMARK 3 THROUGH 426 OR RESID 428 THROUGH 435 OR REMARK 3 RESID 437 THROUGH 443 OR RESID 445 REMARK 3 THROUGH 458)) REMARK 3 ATOM PAIRS NUMBER : 978 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DUV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1000235280. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 10.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 270 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33150 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 64.588 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06800 REMARK 200 FOR THE DATA SET : 20.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.50200 REMARK 200 R SYM FOR SHELL (I) : 0.50200 REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.0 AMMONIUM SULFATE, 0.2 M LITHIUM REMARK 280 SULFATE, CAPS PH10.5, VAPOR DIFFUSION, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.15667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.31333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 74.31333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 37.15667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ONLY ONE DOMAIN CRYSTALLIZED AT THE N-TERMINUS AND THE C-TERMINUS REMARK 400 HAS BEEN EITHER CLEAVED OR DISORDER IN THE CRYSTAL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 347 REMARK 465 SER A 348 REMARK 465 SER B 347 REMARK 465 SER B 348 REMARK 465 LYS B 349 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 448 NE ARG B 444 2.07 REMARK 500 O HOH B 684 O HOH B 689 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU B 383 CA - CB - CG ANGL. DEV. = 14.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0S6 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0S6 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 0S6 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 506 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FOLLOWING SEQUENCE WAS PROBABLY CLEAVED DURING CRYSTALLIZATION REMARK 999 DEPEEPVVAVSSPAVPPPTKVVAPPSSSDSSSDSSSDSDSSTDDSEEE RAQRLAELQEQLKAVHEQL REMARK 999 AALSQPQQNKPKKKEKDKKEKKKEKHKRKEEVEENKKSKAKEPPPKKTKKNNSSNSNVSKK EPAPMK REMARK 999 REMARK 999 SKPPPTYESEEEDKCKPMSYEEKRQLSLDINKLPGEKLGRVVHIIQSREPSLKNSNPDEIEIDFETLK DBREF 6DUV A 347 458 UNP O60885 BRD4_HUMAN 347 458 DBREF 6DUV B 347 458 UNP O60885 BRD4_HUMAN 347 458 SEQRES 1 A 112 SER SER LYS VAL SER GLU GLN LEU LYS CYS CYS SER GLY SEQRES 2 A 112 ILE LEU LYS GLU MET PHE ALA LYS LYS HIS ALA ALA TYR SEQRES 3 A 112 ALA TRP PRO PHE TYR LYS PRO VAL ASP VAL GLU ALA LEU SEQRES 4 A 112 GLY LEU HIS ASP TYR CYS ASP ILE ILE LYS HIS PRO MET SEQRES 5 A 112 ASP MET SER THR ILE LYS SER LYS LEU GLU ALA ARG GLU SEQRES 6 A 112 TYR ARG ASP ALA GLN GLU PHE GLY ALA ASP VAL ARG LEU SEQRES 7 A 112 MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS SEQRES 8 A 112 GLU VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE SEQRES 9 A 112 GLU MET ARG PHE ALA LYS MET PRO SEQRES 1 B 112 SER SER LYS VAL SER GLU GLN LEU LYS CYS CYS SER GLY SEQRES 2 B 112 ILE LEU LYS GLU MET PHE ALA LYS LYS HIS ALA ALA TYR SEQRES 3 B 112 ALA TRP PRO PHE TYR LYS PRO VAL ASP VAL GLU ALA LEU SEQRES 4 B 112 GLY LEU HIS ASP TYR CYS ASP ILE ILE LYS HIS PRO MET SEQRES 5 B 112 ASP MET SER THR ILE LYS SER LYS LEU GLU ALA ARG GLU SEQRES 6 B 112 TYR ARG ASP ALA GLN GLU PHE GLY ALA ASP VAL ARG LEU SEQRES 7 B 112 MET PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS SEQRES 8 B 112 GLU VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE SEQRES 9 B 112 GLU MET ARG PHE ALA LYS MET PRO HET 0S6 A 501 28 HET 0S6 A 502 28 HET EDO A 503 4 HET EDO A 504 4 HET 0S6 B 501 28 HET EDO B 502 4 HET EDO B 503 4 HET EDO B 504 4 HET EDO B 505 4 HET EDO B 506 4 HETNAM 0S6 METHYL [(6S)-4-(4-CHLOROPHENYL)-2,3,9-TRIMETHYL-6H- HETNAM 2 0S6 THIENO[3,2-F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPIN-6- HETNAM 3 0S6 YL]ACETATE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 0S6 3(C20 H19 CL N4 O2 S) FORMUL 5 EDO 7(C2 H6 O2) FORMUL 13 HOH *190(H2 O) HELIX 1 AA1 LYS A 349 PHE A 365 1 17 HELIX 2 AA2 ALA A 366 LYS A 368 5 3 HELIX 3 AA3 HIS A 369 TRP A 374 1 6 HELIX 4 AA4 PRO A 375 TYR A 377 5 3 HELIX 5 AA5 ASP A 389 ILE A 394 1 6 HELIX 6 AA6 ASP A 399 ALA A 409 1 11 HELIX 7 AA7 ASP A 414 ASN A 433 1 20 HELIX 8 AA8 HIS A 437 LYS A 456 1 20 HELIX 9 AA9 SER B 351 PHE B 365 1 15 HELIX 10 AB1 ALA B 366 LYS B 368 5 3 HELIX 11 AB2 HIS B 369 TRP B 374 1 6 HELIX 12 AB3 PRO B 375 TYR B 377 5 3 HELIX 13 AB4 ASP B 381 GLY B 386 1 6 HELIX 14 AB5 ASP B 389 ILE B 394 1 6 HELIX 15 AB6 ASP B 399 ALA B 409 1 11 HELIX 16 AB7 ASP B 414 ASN B 433 1 20 HELIX 17 AB8 HIS B 437 LYS B 456 1 20 SITE 1 AC1 12 TRP A 374 PRO A 375 PHE A 376 LEU A 387 SITE 2 AC1 12 ASN A 433 GLU A 438 VAL A 439 0S6 A 502 SITE 3 AC1 12 HOH A 608 HOH A 611 HOH A 666 TRP B 374 SITE 1 AC2 15 LEU A 385 SER A 405 GLU A 408 ALA A 409 SITE 2 AC2 15 ARG A 410 TYR A 432 PRO A 434 HIS A 437 SITE 3 AC2 15 0S6 A 501 HOH A 623 HOH A 640 TRP B 374 SITE 4 AC2 15 ALA B 384 LEU B 385 EDO B 504 SITE 1 AC3 3 LEU A 354 SER A 358 HOH A 618 SITE 1 AC4 7 LEU A 424 SER A 427 HOH A 603 HOH A 606 SITE 2 AC4 7 HOH A 632 ARG B 423 PHE B 454 SITE 1 AC5 11 LEU A 385 GLU A 411 TRP B 374 PRO B 375 SITE 2 AC5 11 PHE B 376 ASN B 433 HIS B 437 VAL B 439 SITE 3 AC5 11 MET B 442 HOH B 608 HOH B 609 SITE 1 AC6 3 HIS A 396 PRO A 397 HOH B 619 SITE 1 AC7 6 HIS A 437 GLU A 438 0S6 A 502 HOH B 606 SITE 2 AC7 6 HOH B 655 HOH B 660 SITE 1 AC8 3 ALA B 366 LYS B 367 LYS B 368 SITE 1 AC9 4 PHE B 365 LYS B 404 HOH B 603 HOH B 657 CRYST1 74.580 74.580 111.470 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013408 0.007741 0.000000 0.00000 SCALE2 0.000000 0.015483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008971 0.00000